EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Circulating Tumor Cell Detection for Therapeutic and Prognostic Roles in Breast Cancer

Saiying Ma iD, Xiaojia Wang iD, Peter Ping Lin, Lei Lei

Cancer Medicine · 2025

DOI: 10.1002/cam4.70902 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancer Medicine, 2025. Verfasst von Saiying Ma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Breast Neoplasms, Cytodiagnosis. Die Arbeit nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program/International Cooperation in Science and Technology Innovation/Key Special Projects of Hong Kong, Macao, and Taiw…, Natural Science Foundation of Zhejiang Province, China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Circulating tumor cells (CTCs) are pivotal liquid biopsy (LB) biomarkers for breast cancer (BC), offering non‐invasive insights into tumor progression and metastasis. Despite their clinical promise, CTC detection remains technically challenging due to their extreme rarity in peripheral blood.

Methods

This review systematically evaluates CTC detection methodologies, including immunoaffinity‐based approaches and biophysical techniques, which exhibit inherent trade‐offs in sensitivity, specificity, and compatibility with downstream analyses. Furthermore, post‐isolation molecular characterization methods spanning genomic, transcriptomic, and proteomic analyses are also critically assessed. Key Findings CTC molecular profiling holds significant clinical relevance, enabling early diagnosis, prognostic stratification, and real‐time monitoring of therapeutic response. Baseline CTC counts or quantitative/phenotypic changes during treatment inform therapeutic decision‐making, predict drug resistance, and correlate with recurrence risk and metastatic progression.

Conclusion

Multimodal analysis integrating CTC morphology, surface markers, and molecular alterations advances precision therapy. However, standardization of detection platforms and clinical validation of CTC‐guided protocols remain essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingBreast NeoplasmsCytodiagnosisHumansFemaleLiquid BiopsyPrognosis

Stichwörter der Autor:innen

breast cancercirculating tumor cellcirculating tumor endothelial celldetecting technologyliquid biopsy

Autor:innen und Institutionen

  • Zhejiang Chinese Medical University, Hangzhou, China.
  • Zhejiang Cancer Hospital, Hangzhou, China.
  • Cytelligen, San Diego, California, USA.

ORCID-Profile: Saiying Ma, Xiaojia Wang

Förderung

  • National Key Research and Development Program/International Cooperation in Science and Technology Innovation/Key Special Projects of Hong Kong, Macao, and Taiw…
  • Natural Science Foundation of Zhejiang Province, China
  • National Key Research and Development Program of China
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Ma, S., Wang, X., Lin, P. P., & Lei, L. (2025). Circulating Tumor Cell Detection for Therapeutic and Prognostic Roles in Breast Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.70902

Vancouver

Ma S, Wang X, Lin PP, Lei L. Circulating Tumor Cell Detection for Therapeutic and Prognostic Roles in Breast Cancer. Cancer Medicine. 2025. doi:10.1002/cam4.70902

BibTeX
@article{Ma2025,
  author = {Ma, Saiying and Wang, Xiaojia and Lin, Peter Ping and Lei, Lei},
  title = {Circulating Tumor Cell Detection for Therapeutic and Prognostic Roles in Breast Cancer},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70902}
}
Kostenlos starten →